$45.87 $0.52 (1.1%)

04:00 PM EST on 12/06/19

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

CAPS Rating: No stars

Current Price $45.87 Mkt Cap $1.9B
Open $45.65 P/E Ratio 879.41
Prev. Close $45.35 Div. (Yield) $0.00 (0.0%)
Daily Range $45.43 - $46.10 Volume 306,531
52-Wk Range $34.64 - $49.50 Avg. Daily Vol. 494,473

Caps

How do you think NASDAQ:PCRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

48 Outperform
12 Underperform
 

All-Star Players

8 Outperform
7 Underperform
 

Wall Street

5 Outperform
2 Underperform
 

Top NASDAQ:PCRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFSarahGen (96.96)
Submitted August 04, 2016

non opioid pain meds

zzlangerhans (99.72)
Submitted January 20, 2012

The commercial success of Exparel is a tough call to make. Intuitively, the drug seems to be filling an important niche in post-operative pain management. But empirical evidence tells us that launches of new drugs are usually slow, and expecially in… More

NASDAQ:PCRX VS S&P 500 (SPY)

Fools bullish on NASDAQ:PCRX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about PCRX.

Recs

1
Member Avatar TMFSarahGen (96.96) Submitted: 8/4/2016 2:50:53 PM : Outperform Start Price: $44.87 NASDAQ:PCRX Score: -43.33

non opioid pain meds

Recs

0
Member Avatar MSUalum (27.23) Submitted: 5/2/2016 1:47:23 PM : Outperform Start Price: $65.97 NASDAQ:PCRX Score: -97.57

Has massive potential but further to slide after thus ER. Could also be a buyout target.

Recs

0
Member Avatar yoder9339 (< 20) Submitted: 9/7/2014 6:49:22 PM : Outperform Start Price: $102.36 NASDAQ:PCRX Score: -111.89

Their product Exparel will continue to gain market share as inpatient surgeries transition to outpatient. This product is gaining traction in the joint replacement procedures. It is a game changer for physicians, patients and surgery centers.

Leaderboard

Find the members with the highest scoring picks in PCRX.

Score Leader

IPOMizzouFanVan

IPOMizzouFanVan (< 20) Score: +416.62

The Score Leader is the player with the highest score across all their picks in PCRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
IPOMizzouFanVan < 20 2/7/2011 Outperform 3Y $7.01 +554.82% +138.20% +416.62 0 Comment
ChristopherHamel < 20 11/28/2011 Outperform 5Y $7.25 +532.69% +163.38% +369.31 0 Comment
locochango 88.01 11/7/2011 Outperform 5Y $7.66 +498.83% +151.10% +347.73 0 Comment
PatientTrader < 20 11/2/2011 Outperform 5Y $8.89 +415.97% +153.83% +262.14 0 Comment
FUZZYMINKINS < 20 8/1/2011 Outperform 5Y $10.06 +355.96% +140.64% +215.33 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. schwein2010 33.85 9/19/2011 5/8/2013 Outperform 5Y $10.58 +333.55% +161.68% +171.88 0 Comment
PharmaD < 20 10/27/2011 7/17/2012 Outperform 3Y $11.39 +302.72% +146.69% +156.03 2 Comments
jsrichards 88.88 6/11/2012 Outperform 3Y $13.06 +251.23% +137.84% +113.39 1 Comment
CocaineOrStock 99.24 7/15/2014 Underperform 5Y $86.81 -47.16% +59.56% +106.72 0 Comment
wahodges 88.76 5/19/2014 Underperform 5Y $75.09 -38.91% +67.75% +106.66 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PCRX.